Home › Mesothelioma
Pag-aaral pangklinika para sa Mesothelioma na nagre-recruit sa U.S.
46 pag-aaral para sa Mesothelioma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX16 pag-aaral
- New York City, NY11 pag-aaral
- Chicago, IL10 pag-aaral
- Washington, DC9 pag-aaral
- Boston, MA8 pag-aaral
- Nashville, TN8 pag-aaral
- Arlington, VA7 pag-aaral
- Los Angeles, CA6 pag-aaral
- Rochester, MN6 pag-aaral
- Seattle, WA6 pag-aaral
- Pittsburgh, PA6 pag-aaral
- Philadelphia, PA6 pag-aaral
- San Diego, CA5 pag-aaral
- Phoenix, AZ5 pag-aaral
- Columbus, OH5 pag-aaral
- Jacksonville, FL5 pag-aaral
- Edison, NJ5 pag-aaral
- Omaha, NE4 pag-aaral
- St. Louis, MO4 pag-aaral
- Tampa, FL4 pag-aaral
- Denver, CO4 pag-aaral
- San Antonio, TX4 pag-aaral
- Dallas, TX4 pag-aaral
- Queens, NY4 pag-aaral
- Irving, TX3 pag-aaral
- Santa Monica, CA3 pag-aaral
- Mountain View, CA3 pag-aaral
- Portland, OR3 pag-aaral
- Cleveland, OH3 pag-aaral
- Miami, FL3 pag-aaral
- Durham, NC3 pag-aaral
- Fort Worth, TX3 pag-aaral
- Santa Rosa, CA3 pag-aaral
- Grand Rapids, MI3 pag-aaral
- Detroit, MI3 pag-aaral
- Staten Island, NY3 pag-aaral
- Greenburgh, NY3 pag-aaral
- New Rochelle, NY3 pag-aaral
- East Norwalk, CT3 pag-aaral
Ayos sa estado
- Arizona8 pag-aaral
- California13 pag-aaral
- Colorado9 pag-aaral
- Florida13 pag-aaral
- Georgia3 pag-aaral
- Illinois12 pag-aaral
- Kansas3 pag-aaral
- Maryland10 pag-aaral
- Massachusetts10 pag-aaral
- Michigan6 pag-aaral
- Minnesota9 pag-aaral
- Missouri5 pag-aaral
- Nebraska4 pag-aaral
- New Jersey8 pag-aaral
- New York12 pag-aaral
- North Carolina4 pag-aaral
- Ohio10 pag-aaral
- Oregon3 pag-aaral
- Pennsylvania13 pag-aaral
- Tennessee8 pag-aaral
- Texas20 pag-aaral
- Utah4 pag-aaral
- Virginia9 pag-aaral
- Washington6 pag-aaral
- Wisconsin3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277413Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 30 hanggang 120 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT04431024Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04981119A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06057935Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
Nagre-recruit
Edad 30 hanggang 85 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06037941Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
Nagre-recruitPhase 2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05960773Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Nagre-recruitObservasyonal na pag-aaral
Edad 2 hanggang 120 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT00242723A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07705334Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06566079TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04969315Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05732831SW-682 in Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06251310Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05245500Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Nagre-recruitObservasyonal na pag-aaral
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT01950572Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1
Nagre-recruitObservasyonal na pag-aaral
Edad 2 hanggang 120 · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT03830229Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06885697A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04104776Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
Nagre-recruitPhase 1
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07192900Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT05873686Lead-212 PSV359 Therapy for Patients With Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT06710756Integrated Cancer Repository for Cancer Research
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT05568680CT-95 in Advanced Cancers Associated With Mesothelin Expression
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT06756035A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT06051695Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.